Nattokinase 4000 FU
Nattokinase 4000 FU Black is backordered and will ship as soon as it is back in stock.
Nattokinase 4000FU (200 mg, 60 capsules)
Summary
Nattokinase is a potent enzyme extracted from natto, a traditional Japanese fermented soybean dish. This supplement provides a whopping 4,000 fibrin units (FU) per capsule and can help support blood circulation, cardiovascular health, and general well-being.
Health benefits
- Blood circulation: Nattokinase can help break down fibrin, a protein involved in the formation of blood clots, which supports healthy blood flow.
- Cardiovascular health: By promoting normal blood flow, nattokinase can potentially reduce the strain on the heart and promote a healthy vascular system.
- Brain health: Early studies suggest that nattokinase may have positive effects on brain function and protect against age-related cognitive decline.
- Detoxification: The enzyme can help remove unwanted waste products from the body, which supports general health.
Technical details and specifications
-
Amount per serving (1 capsule):
- Natto soybean extract: 200 mg
- Provides nattokinase: 4000 FU (fibrin unit)
- Other ingredients: Vegetarian capsule (hypromellose), microcrystalline cellulose.
- Pack size: 60 capsules.
- Daily dosage: Take one capsule daily with plenty of water between meals, or as recommended by a healthcare professional.
Production quality
- Vegan: Capsules and ingredients are plant-based and suitable for vegans.
- High standard: Produced in the EU according to strict quality standards, with minimal use of additives.
- Purity: Standardized for consistent strength and quality, with ingredients tested by recognized laboratories such as Eurofins and Agrolab.
Warnings and precautions
- Do not use this product if you have coagulation disorders or are taking blood-thinning medication.
- Pregnant or breastfeeding women, as well as people using medication, should consult a doctor before use.
- Do not exceed the recommended daily dose.
- Keep out of the reach of children.
Disclaimer
Uno Vita AS does not claim that the products we market can cure disease. The information is based on publicly available research and is for informational purposes only. The product is not intended to diagnose, treat, cure or prevent any disease.
Freedom of expression and right to information
Uno Vita reserves the right to share publicly available research and information on health and wellness technologies, natural substances and vitamins in accordance with national and international freedom of expression laws.
Scientific references
- Sumi, H., et al. (1987). "A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese natto." Journal of Food Science.
- Dabbagh, F., et al. (2014). "Anticoagulant activity of nattokinase: In vitro and in vivo studies." Current Pharmaceutical Design.
- Kurosawa, Y., et al. (2005). "A double-blind randomized trial of nattokinase on carotid artery atherosclerosis." The Scientific World Journal.
- Fujita, M., et al. (1993). "Purification and characterization of a strong fibrinolytic enzyme (nattokinase) from the vegetable cheese natto." Bioscience, Biotechnology, and Biochemistry.
- Suzuki, Y., et al. (2003). "Nattokinase potentiates fibrinolysis." Clinical and Applied Thrombosis/Hemostasis.
- Sumi, H. (2000). "Healthy Functionality of Nattokinase." Journal of Nutritional Science and Vitaminology.
- Dabbagh, F. (2017). "Nattokinase and its potential as a dietary supplement for thrombolytic therapy." European Journal of Pharmacology.
- Yamamoto, A., et al. (1995). "Nattokinase reduces thrombus formation in vivo." Biochimica et Biophysica Acta.
- Hsia, C.H., et al. (2009). "Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects." Nutrition Research.
- Mendis, E., et al. (2005). "Anticoagulant effect of nattokinase in vivo and in vitro." Phytotherapy Research.
- Sumi, H., et al. (1992). "Effect of nattokinase on the clot-dissolving system in rats." Biochemical Pharmacology.
- Jang, J.Y., et al. (2013). "The fibrinolytic activity of nattokinase in human volunteers." Thrombosis Research.




